Our translational findings support the potential importance of Klotho as a new biomarker of post‐MI ventricular injury, even in the setting of preserved renal function and also as a novel therapeutic strategy for the prevention of cardiac events associated with IHD. This evidence concerns the gene KL and myocardial ischemia.